Suspected Invasive Mould Infection clinical trials

Explore recruiting suspected invasive mould infection clinical trials.

Also recruiting in Europe

Suspected Invasive Mould Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 versus Standard of Care (Liposomal Amphotericin B followed by Voriconazole) for Early Antifungal Therapy of Suspected Invasive Mould Infections

Belgium, France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Suspected Invasive Mould Infection trials by city

Suspected Invasive Mould Infection in Toronto Suspected Invasive Mould Infection in Vancouver Suspected Invasive Mould Infection in Montreal Suspected Invasive Mould Infection in Calgary Suspected Invasive Mould Infection in Edmonton Suspected Invasive Mould Infection in Ottawa Suspected Invasive Mould Infection in Winnipeg Suspected Invasive Mould Infection in Quebec City Suspected Invasive Mould Infection in Hamilton Suspected Invasive Mould Infection in Kitchener Suspected Invasive Mould Infection in London Suspected Invasive Mould Infection in Halifax Suspected Invasive Mould Infection in New York Suspected Invasive Mould Infection in Los Angeles Suspected Invasive Mould Infection in Chicago Suspected Invasive Mould Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease